Notice ID: d28a6d76ddb943fb86c8b4498e3f8a39Combined Synopsis/Solicitation
Monoclonal Antibody Production
Archived on September 28, 2022. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 5:00 PM UTC−04:00
- Posted
- September 1, 2022
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- Total Small Business Set-Aside (FAR 19.5)
- NAICS
- 325414: Biological Product (except Diagnostic) Manufacturing
- Agency
- Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Notice details
- Office
- FDA OFFICE OF ACQ GRANT SVCS
- PSC
- AJ13: GENERAL SCIENCE & TECHNOLOGY R&D SVCS; GENERAL SCIENCE & TECHNOLOGY; EXPERIMENTAL DEVELOPMENT
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- FDA-RFQ-1255308
- Notice ID
- d28a6d76ddb943fb86c8b4498e3f8a39
Description
See attached document.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
FDA-RFQ-1255308- Combined Synopsis
- Combined SynopsisCurrentSep 1, 2022
Monoclonal Antibody Production
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
FDA-RFQ-1255308
Archive Date
Sep 28, 2022
Office Address
Beltsville, MD, 20705